Measurement of hepatic venous pressure gradient is feasible and safe in children

Jessica Woolfson1, Philip John, Binita Kamath

  • 1*Division of Gastroenterology, Hepatology, and Nutrition †Department of Paediatrics, University of Toronto ‡Division of Interventional Radiology, The Hospital for Sick Children, Toronto, Ontario, Canada.

Insights

Hepatic venous pressure gradient (HVPG) measurement is safe and feasible in pediatric patients with severe liver disease. This study assessed the safety and feasibility of HVPG in children, finding no complications.

Area of Science:

  • Pediatric Gastroenterology
  • Hepatology
  • Interventional Radiology

Background:

  • Hepatic venous pressure gradient (HVPG) is a key metric for assessing portal hypertension in adults.
  • Data on HVPG measurement in pediatric populations is limited.
  • Understanding HVPG in children is crucial for managing liver disease.

Purpose of the Study:

  • To evaluate the feasibility of performing HVPG measurements in children.
  • To assess the safety profile of HVPG measurements in pediatric patients.
  • To establish baseline HVPG values in a pediatric cohort.

Main Methods:

  • Retrospective review of 49 pediatric patients undergoing HVPG measurement between 2000 and 2011.
  • Data collected included clinical details, procedural information, and outcomes.
  • Analysis of HVPG values and complication rates.

Main Results:

  • 52 HVPG measurements were performed in 49 children (mean age 8.2 years).
  • Diagnoses varied, including acute liver failure, cirrhosis, and post-transplant states.
  • No complications were reported; HVPG values ranged from 0-28 mmHg, with 30 patients showing elevated levels (>6 mmHg).

Conclusions:

  • HVPG measurement is a feasible and safe procedure in children with severe liver disease.
  • Further research is needed to define the clinical utility of HVPG in pediatric portal hypertension and acute liver conditions.
Abstract

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
Pre-Procedural Guidelines for Assessing Blood Pressure01:10

Pre-Procedural Guidelines for Assessing Blood Pressure

Accurate blood pressure assessment is crucial for diagnosing and managing various health conditions. To ensure the reliability of these measurements, healthcare professionals must adhere to standardized pre-procedural guidelines. These guidelines enhance patient safety and improve the overall quality of healthcare. The following steps are essential for obtaining accurate and consistent blood pressure readings, from using the appropriate tools to ensuring effective communication with the patient.